Intestinal dysbiosis in autoimmune diabetes is correlated with poor glycemic control and increased interleukin-6: A pilot study
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.3389/fimmu.2018.01689 http://hdl.handle.net/11449/171263 |
Resumo: | Intestinal dysbiosis associated with immunological deregulation, leaky gut, bacterial translocation, and systemic inflammation has been associated with autoimmune diseases, such as type 1 diabetes (T1D). The aim of this study was to investigate the intestinal dysbiosis in T1D patients and correlate these results with clinical parameters and cytokines. The present study was approved by the Barretos Cancer Hospital (Process number 903/2014), and all participants have signed the informed consent in accordance with the Declaration of Helsinki, and answered a questionnaire about dietary habits. Stool samples were used for bacterial 16S sequencing by MiSeq Illumina platform. IL-2, IL-4, IL-6, IL-10, IL-17A, TNF, and IFN-γ plasma concentrations were determined by cytometric bead arrays. The Pearson's chi-square, Mann-Whitney and Spearman correlation were used for statistical analyses. Alpha and beta diversities were conducted by using an annotated observed taxonomic units table. This study included 20 patients and 28 controls, and we found significant differences (P < 0.05) among consumption of vegetables, proteins, milk and derivatives, spicy food, and canned food when we compare patients and controls. We detected intestinal dysbiosis in T1D patients when we performed the beta diversity analysis (P = 0.01). The prevalent species found in patients' stool were the Gram-negatives Bacteroides vulgatus, Bacteroides rodentium, Prevotella copri, and Bacteroides xylanisolvens. The inflammatory interleukin-6 was significantly increased (P = 0.017) in patients' plasma. Furthermore, we showed correlation among patients with poor glycemic control, represented by high levels of HbA1C percentages and Bacteroidetes, Lactobacillales, and Bacteroides dorei relative abundances. We concluded that there are different gut microbiota profiles between T1D patients and healthy controls. The prevalent Gram-negative species in T1D patients could be involved in the leaky gut, bacterial translocation, and poor glycemic control. However, additional studies, with larger cohorts, are required to determine a signature of the intestinal microbiota in T1D patients in the Brazilian population. |
id |
UNSP_14ee665b515f41c18c6a16c5ac9153e4 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/171263 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Intestinal dysbiosis in autoimmune diabetes is correlated with poor glycemic control and increased interleukin-6: A pilot studyDietary habitsGlycemic controlInflammatory cytokinesInterleukin-6Intestinal dysbiosisType 1 diabetesIntestinal dysbiosis associated with immunological deregulation, leaky gut, bacterial translocation, and systemic inflammation has been associated with autoimmune diseases, such as type 1 diabetes (T1D). The aim of this study was to investigate the intestinal dysbiosis in T1D patients and correlate these results with clinical parameters and cytokines. The present study was approved by the Barretos Cancer Hospital (Process number 903/2014), and all participants have signed the informed consent in accordance with the Declaration of Helsinki, and answered a questionnaire about dietary habits. Stool samples were used for bacterial 16S sequencing by MiSeq Illumina platform. IL-2, IL-4, IL-6, IL-10, IL-17A, TNF, and IFN-γ plasma concentrations were determined by cytometric bead arrays. The Pearson's chi-square, Mann-Whitney and Spearman correlation were used for statistical analyses. Alpha and beta diversities were conducted by using an annotated observed taxonomic units table. This study included 20 patients and 28 controls, and we found significant differences (P < 0.05) among consumption of vegetables, proteins, milk and derivatives, spicy food, and canned food when we compare patients and controls. We detected intestinal dysbiosis in T1D patients when we performed the beta diversity analysis (P = 0.01). The prevalent species found in patients' stool were the Gram-negatives Bacteroides vulgatus, Bacteroides rodentium, Prevotella copri, and Bacteroides xylanisolvens. The inflammatory interleukin-6 was significantly increased (P = 0.017) in patients' plasma. Furthermore, we showed correlation among patients with poor glycemic control, represented by high levels of HbA1C percentages and Bacteroidetes, Lactobacillales, and Bacteroides dorei relative abundances. We concluded that there are different gut microbiota profiles between T1D patients and healthy controls. The prevalent Gram-negative species in T1D patients could be involved in the leaky gut, bacterial translocation, and poor glycemic control. However, additional studies, with larger cohorts, are required to determine a signature of the intestinal microbiota in T1D patients in the Brazilian population.Microbiome Study Group School of Health Sciences Dr. Paulo Prata (FACISB)QGene-Solutions and Logistics in HealthBoard of Health from BarretosDepartment of Technology School of Agricultural and Veterinarian Sciences São Paulo State University (UNESP)DNA Consult Genetics and BiotechnologyBiotechnology Department Sao Carlos Federal University UFSCARBarretos Cancer Hospital (HCB)Institute of Biosciences Humanities and Exact Sciences (IBILCE) São Paulo State University (UNESP)Department of Technology School of Agricultural and Veterinarian Sciences São Paulo State University (UNESP)Institute of Biosciences Humanities and Exact Sciences (IBILCE) São Paulo State University (UNESP)School of Health Sciences Dr. Paulo Prata (FACISB)QGene-Solutions and Logistics in HealthBoard of Health from BarretosUniversidade Estadual Paulista (Unesp)DNA Consult Genetics and BiotechnologyUniversidade Federal de São Carlos (UFSCar)Barretos Cancer Hospital (HCB)Higuchi, Bruna StevanatoRodrigues, NatháliaGonzaga, Marina IgnácioPaiolo, João Carlos CicognaStefanutto, NadineOmori, Wellington Pine [UNESP]Pinheiro, Daniel Guariz [UNESP]Brisotti, João LuizMatheucci, EuclidesMariano, Vânia Sammartinode Oliveira, Gislane Lelis Vilela [UNESP]2018-12-11T16:54:38Z2018-12-11T16:54:38Z2018-07-25info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://dx.doi.org/10.3389/fimmu.2018.01689Frontiers in Immunology, v. 9, n. JUL, 2018.1664-3224http://hdl.handle.net/11449/17126310.3389/fimmu.2018.016892-s2.0-850504997052-s2.0-85050499705.pdfScopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengFrontiers in Immunology2,803info:eu-repo/semantics/openAccess2023-11-21T06:11:57Zoai:repositorio.unesp.br:11449/171263Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T18:20:03.790333Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Intestinal dysbiosis in autoimmune diabetes is correlated with poor glycemic control and increased interleukin-6: A pilot study |
title |
Intestinal dysbiosis in autoimmune diabetes is correlated with poor glycemic control and increased interleukin-6: A pilot study |
spellingShingle |
Intestinal dysbiosis in autoimmune diabetes is correlated with poor glycemic control and increased interleukin-6: A pilot study Higuchi, Bruna Stevanato Dietary habits Glycemic control Inflammatory cytokines Interleukin-6 Intestinal dysbiosis Type 1 diabetes |
title_short |
Intestinal dysbiosis in autoimmune diabetes is correlated with poor glycemic control and increased interleukin-6: A pilot study |
title_full |
Intestinal dysbiosis in autoimmune diabetes is correlated with poor glycemic control and increased interleukin-6: A pilot study |
title_fullStr |
Intestinal dysbiosis in autoimmune diabetes is correlated with poor glycemic control and increased interleukin-6: A pilot study |
title_full_unstemmed |
Intestinal dysbiosis in autoimmune diabetes is correlated with poor glycemic control and increased interleukin-6: A pilot study |
title_sort |
Intestinal dysbiosis in autoimmune diabetes is correlated with poor glycemic control and increased interleukin-6: A pilot study |
author |
Higuchi, Bruna Stevanato |
author_facet |
Higuchi, Bruna Stevanato Rodrigues, Nathália Gonzaga, Marina Ignácio Paiolo, João Carlos Cicogna Stefanutto, Nadine Omori, Wellington Pine [UNESP] Pinheiro, Daniel Guariz [UNESP] Brisotti, João Luiz Matheucci, Euclides Mariano, Vânia Sammartino de Oliveira, Gislane Lelis Vilela [UNESP] |
author_role |
author |
author2 |
Rodrigues, Nathália Gonzaga, Marina Ignácio Paiolo, João Carlos Cicogna Stefanutto, Nadine Omori, Wellington Pine [UNESP] Pinheiro, Daniel Guariz [UNESP] Brisotti, João Luiz Matheucci, Euclides Mariano, Vânia Sammartino de Oliveira, Gislane Lelis Vilela [UNESP] |
author2_role |
author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
School of Health Sciences Dr. Paulo Prata (FACISB) QGene-Solutions and Logistics in Health Board of Health from Barretos Universidade Estadual Paulista (Unesp) DNA Consult Genetics and Biotechnology Universidade Federal de São Carlos (UFSCar) Barretos Cancer Hospital (HCB) |
dc.contributor.author.fl_str_mv |
Higuchi, Bruna Stevanato Rodrigues, Nathália Gonzaga, Marina Ignácio Paiolo, João Carlos Cicogna Stefanutto, Nadine Omori, Wellington Pine [UNESP] Pinheiro, Daniel Guariz [UNESP] Brisotti, João Luiz Matheucci, Euclides Mariano, Vânia Sammartino de Oliveira, Gislane Lelis Vilela [UNESP] |
dc.subject.por.fl_str_mv |
Dietary habits Glycemic control Inflammatory cytokines Interleukin-6 Intestinal dysbiosis Type 1 diabetes |
topic |
Dietary habits Glycemic control Inflammatory cytokines Interleukin-6 Intestinal dysbiosis Type 1 diabetes |
description |
Intestinal dysbiosis associated with immunological deregulation, leaky gut, bacterial translocation, and systemic inflammation has been associated with autoimmune diseases, such as type 1 diabetes (T1D). The aim of this study was to investigate the intestinal dysbiosis in T1D patients and correlate these results with clinical parameters and cytokines. The present study was approved by the Barretos Cancer Hospital (Process number 903/2014), and all participants have signed the informed consent in accordance with the Declaration of Helsinki, and answered a questionnaire about dietary habits. Stool samples were used for bacterial 16S sequencing by MiSeq Illumina platform. IL-2, IL-4, IL-6, IL-10, IL-17A, TNF, and IFN-γ plasma concentrations were determined by cytometric bead arrays. The Pearson's chi-square, Mann-Whitney and Spearman correlation were used for statistical analyses. Alpha and beta diversities were conducted by using an annotated observed taxonomic units table. This study included 20 patients and 28 controls, and we found significant differences (P < 0.05) among consumption of vegetables, proteins, milk and derivatives, spicy food, and canned food when we compare patients and controls. We detected intestinal dysbiosis in T1D patients when we performed the beta diversity analysis (P = 0.01). The prevalent species found in patients' stool were the Gram-negatives Bacteroides vulgatus, Bacteroides rodentium, Prevotella copri, and Bacteroides xylanisolvens. The inflammatory interleukin-6 was significantly increased (P = 0.017) in patients' plasma. Furthermore, we showed correlation among patients with poor glycemic control, represented by high levels of HbA1C percentages and Bacteroidetes, Lactobacillales, and Bacteroides dorei relative abundances. We concluded that there are different gut microbiota profiles between T1D patients and healthy controls. The prevalent Gram-negative species in T1D patients could be involved in the leaky gut, bacterial translocation, and poor glycemic control. However, additional studies, with larger cohorts, are required to determine a signature of the intestinal microbiota in T1D patients in the Brazilian population. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-12-11T16:54:38Z 2018-12-11T16:54:38Z 2018-07-25 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.3389/fimmu.2018.01689 Frontiers in Immunology, v. 9, n. JUL, 2018. 1664-3224 http://hdl.handle.net/11449/171263 10.3389/fimmu.2018.01689 2-s2.0-85050499705 2-s2.0-85050499705.pdf |
url |
http://dx.doi.org/10.3389/fimmu.2018.01689 http://hdl.handle.net/11449/171263 |
identifier_str_mv |
Frontiers in Immunology, v. 9, n. JUL, 2018. 1664-3224 10.3389/fimmu.2018.01689 2-s2.0-85050499705 2-s2.0-85050499705.pdf |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Frontiers in Immunology 2,803 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1808128921075449856 |